ADMA Biologics, Inc.
ADMA
$17.02
$0.110.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.91M | 32.06M | 17.81M | -17.64M | 2.57M |
| Total Depreciation and Amortization | 1.94M | 2.05M | 2.11M | 2.10M | 2.09M |
| Total Amortization of Deferred Charges | 252.00K | 227.00K | 253.00K | 707.20K | 721.00K |
| Total Other Non-Cash Items | 3.15M | 2.83M | 2.13M | 28.83M | 2.75M |
| Change in Net Operating Assets | -16.22M | 8.48M | -24.52M | 3.60M | 3.86M |
| Cash from Operations | 25.03M | 45.65M | -2.22M | 17.60M | 11.99M |
| Capital Expenditure | -1.06M | -2.07M | -2.35M | -1.20M | -757.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.00K | -299.00K | -15.00K | -210.00K | -- |
| Cash from Investing | -1.10M | -2.37M | -2.36M | -1.41M | -757.00K |
| Total Debt Issued | -- | -- | -- | 135.00M | -- |
| Total Debt Repaid | -30.00M | -- | -- | -158.59M | 0.00 |
| Issuance of Common Stock | 5.69M | 331.00K | 1.03M | 8.50K | 624.00K |
| Repurchase of Common Stock | -1.16M | -693.00K | -2.48M | -340.50K | -208.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -15.08M | -- |
| Cash from Financing | -25.47M | -362.00K | -1.45M | -38.99M | 416.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.54M | 42.92M | -6.03M | -22.81M | 11.64M |
